Codes / ICD10CM / E09.3591

E09.3591 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug or Chemical Induced Diabetes Mellitus with Proliferative Diabetic Retinopathy Without Macular Edema, Right Eye (ICD-10 Code: E09.3591)

Summary

Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to advanced eye complications. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and associated retinal damage. Proliferative diabetic retinopathy is characterized by abnormal blood vessel growth in the retina, which can threaten vision, while the absence of macular edema indicates no swelling in the macula. The right eye is specifically affected in this case.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to proliferative diabetic retinopathy due to damage to blood vessels in the retina. The right eye involvement is a specific anatomical detail of the condition.

Risk Factors

  • Use of medications known to affect glucose metabolism (e.g., steroids, antiretrovirals).
  • Exposure to chemicals or toxins that disrupt endocrine function.
  • Pre-existing metabolic conditions that increase susceptibility to drug-induced effects.
  • Prolonged or high-dose exposure to the causative agent.
  • Uncontrolled blood sugar levels prior to or during exposure.

Symptoms

  • Blurred or distorted vision in the right eye.
  • Floaters or spots in the visual field of the right eye.
  • Difficulty seeing in low light or at night.
  • Sudden vision loss in the right eye (rare but possible).
  • No symptoms of macular edema (e.g., central vision swelling or distortion).

Diagnosis

Diagnosis involves a comprehensive eye exam, including dilated retinal imaging, to assess for proliferative diabetic retinopathy and rule out macular edema. Blood tests may confirm hyperglycemia and drug or chemical exposure. Fluorescein angiography or optical coherence tomography (OCT) can help evaluate retinal blood vessel growth and macular status. The right eye is specifically examined to confirm involvement.

Treatment Options

  • Managing blood sugar levels through medication adjustments or discontinuation of the causative agent.
  • Laser photocoagulation or anti-VEGF injections to treat abnormal blood vessel growth in the right eye.
  • Regular monitoring of the right eye to detect progression or complications.
  • Blood pressure and cholesterol management to reduce retinal damage risk.

Prognosis and Follow-Up

Prognosis depends on early detection and control of blood sugar levels. With proper treatment, vision loss may be prevented or slowed. Regular follow-up eye exams are essential to monitor the right eye and address any changes. Untreated proliferative retinopathy can lead to severe vision loss or blindness.

Complications

  • Severe vision loss or blindness in the right eye.
  • Retinal detachment due to abnormal blood vessel growth.
  • Glaucoma from new blood vessel formation.
  • Increased risk of other diabetes-related complications (e.g., kidney or nerve damage).

Lifestyle & Prevention

  • Avoid or limit exposure to known glucose-disrupting medications or chemicals.
  • Maintain a healthy diet and exercise routine to support metabolic health.
  • Monitor blood sugar levels regularly if using high-risk medications.
  • Quit smoking, as it worsens retinal damage.
  • Attend routine eye exams, especially if at risk for drug-induced diabetes.

When to Seek Professional Help

  • Sudden changes in vision in the right eye (e.g., blurriness, floaters).
  • Persistent eye pain or redness in the right eye.
  • Difficulty performing daily tasks due to vision impairment.
  • New or worsening symptoms after starting a new medication or chemical exposure.

Tips for Medical Coders

Document the specific eye involvement (right eye) and confirm the absence of macular edema. Ensure the causative drug or chemical is clearly linked to the diabetes and retinopathy. Use additional codes for any underlying conditions or treatments as needed, but avoid specifying unrelated codes. Verify that the documentation supports the right-eye specificity and proliferative retinopathy without macular edema.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

E09.3591 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.